NIH-funded research R01 grant

Why light-sensing cells die in inherited retinal disorders

Official title: Mechanism of photoreceptor cell degeneration in animal models of retinal diseases

Funded at University of Houston · NIH-11377989 · Data updated 2026-11-12

This research looks at how PRPH2 gene changes cause photoreceptors to break down in people with inherited retinal degeneration, aiming to guide future treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 1995
Project endFebruary 28, 2030
Funding year2026
Award (this year)$563,281
NIH project number5R01EY010609-29
Project IDNIH-11377989 on NIH RePORTER

Who could benefit from this research

Could help

People with inherited retinal degeneration linked to PRPH2 mutations—including certain forms of retinitis pigmentosa and macular/pattern dystrophies—would be most relevant to this research.

Less likely to help

Patients whose vision loss stems from unrelated causes or from advanced, irreversible retinal scarring are unlikely to gain direct benefit from this basic lab-focused work.

What this research studies

From my perspective as a patient, the team uses animal models that carry the same PRPH2 changes seen in people to study how photoreceptor outer segments form and fall apart. They focus on how PRPH2 and its partner ROM1 shape the tiny membrane structures in rods and cones and map the other proteins that interact with PRPH2. The lab compares differences between rods and cones to explain why some cells die while others hold on, and they test how precise amounts of PRPH2 affect cell survival. Their findings are meant to point toward targets or strategies that could be developed into therapies down the road.

Why it matters

Potential benefit: If successful, this work could identify molecular targets or dosing strategies that help prevent or slow vision loss from PRPH2-related inherited retinal diseases.

How similar studies have gone: Related animal-model studies have improved understanding of photoreceptor biology, but translating those findings into widely effective clinical treatments for PRPH2 disorders remains limited so far.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Naash, Muna I. — University of Houston
  • Study coordinator: Naash, Muna I.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.